Siu Christine 4
4 · Eidos Therapeutics, Inc. · Filed Dec 11, 2019
Insider Transaction Report
Form 4
Siu Christine
See Remarks
Transactions
- Sale
Common Stock
2019-12-09$60.05/sh−901$54,101→ 36,470 total - Exercise/Conversion
Common Stock
2019-12-09$0.59/sh+10,000$5,900→ 46,470 total - Sale
Common Stock
2019-12-09$59.62/sh−9,099$542,469→ 37,371 total - Exercise/Conversion
Stock Option (right to buy)
2019-12-09−10,000→ 152,191 totalExercise: $0.59Exp: 2027-12-21→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Represents the weighted average sale price of the shares sold from $59.00 to $59.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in footnotes 1 and 2.
- [F2]Represents the weighted average sale price of the shares sold from $60.01 to $60.115 per share.
- [F3]The shares subject to this option vest and become exercisable in 48 equal monthly installments after December 1, 2017, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.